Biotinylated Human ACE2 / ACEH Protein, His,Avitag? (MALS verified)
分子別名(Synonym)
ACE-2,ACEH,ACE2
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Biotinylated Human ACE2, His,Avitag (AC2-H82E6) is expressed from human 293 cells (HEK293). It contains AA Gln 18 - Ser 740 (Accession # Q9BYF1-1).
Predicted N-terminus: Gln 18
蛋白結(jié)構(gòu)(Molecular Characterization)

This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag?).
The protein has a calculated MW of 87.2 kDa. The protein migrates as 95-125 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
標(biāo)記(Labeling)
Biotinylation of this product is performed using Avitag? technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.
蛋白標(biāo)記度(Protein Ratio)
Passed as determined by the HABA assay / binding ELISA.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH8.0 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.


背景(Background)
血管緊張素轉(zhuǎn)換酶2(ACE2)也稱為ACEH(ACE同源物),是一種與ACE具有相當(dāng)同源性的完整膜蛋白,屬于肽酶M2家族。ACE2是一種外肽酶,催化血管緊張素I轉(zhuǎn)化為九肽血管緊張素,或血管緊張素II轉(zhuǎn)化為血管緊張素1-7。ACE2可能是心臟功能的重要調(diào)節(jié)因子。在人類冠狀病毒SARS和HCoV-NL63感染的情況下,ACE-2作為兩種冠狀病毒刺突糖蛋白的功能受體。ACE2被氯化物和氟化物激活,但不被溴化物激活,被MLN-4760、cFP_Leu和EDTA抑制,但不受ACE抑制劑利諾昔普利、卡托普利和依那普利的抑制。ACE2在pH 6至9范圍內(nèi)具有活性,在1M NaCl的存在下,最適pH為6.5。
關(guān)鍵字: ACE2;ACE2蛋白;ACE2重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。